
Michael Smith
Articles
-
Mar 30, 2024 |
journals.sagepub.com | Alexandria Bontrager |Andrew Medvecz |Candice Smith |Michael Smith |Michaël Smith
Key Takeaways•Excess length of stay, the days between “medical readiness” and discharge, were not associated with insurance status. •Although uninsured patients were the youngest and had the least baseline comorbidities, they had the longest length of stay after regression analysis.
-
Mar 18, 2024 |
journals.sagepub.com | Aaron D. Sciascia |Michael Smith |Michaël Smith |Logan Mattingly |Joseph Holstedt
Skip to main contentIntended for healthcare professionalsGet full access to this articleView all access and purchase options for this article. References1. Camp CL, Zajac JM, Pearson DB, et al. Decreased shoulder external rotation and flexion are greater predictors of injury than internal rotation deficits: analysis of 132 pitcher seasons in professional baseball. Arthroscopy. 2017;33(9):1629-1636. 2. Cicchetti DV.
-
Feb 28, 2024 |
aiche.onlinelibrary.wiley.com | Ping Xu |Yu Ou |Michael Smith |Michaël Smith |Jim Paulson
CONFLICT OF INTEREST STATEMENT The authors declare that they have no competing financial interests. All authors are employees of Bristol Myers Squibb. Supporting Information Filename Description btpr3438-sup-0001-Supinfo.docWord document, 841 KB Data S1. Supporting Information. REFERENCES 1, , , . N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins. Eur J Pharm Biopharm.
-
Feb 26, 2023 |
pubs.acs.org | Sepehr Dehghani-Ghahnaviyeh |Michael Smith |Michaël Smith |Yan Xia |Athanasios Dousis
AbstractLipid nanoparticles (LNPs) containing ionizable aminolipids are among the leading platforms for the successful delivery of nucleic-acid-based therapeutics, including messenger RNA (mRNA). The two recently FDA-approved COVID-19 vaccines developed by Moderna and Pfizer/BioNTech belong to this category.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →